Pharmacological Class
Lipid-lowering and hypotriglyceridaemia.
Indications
- Reduction of pure hypercholesterolemia (type Ila) or mixed (type IIb and III) in addition to an adapted and diligent diet.
- Reduction of coronary events in hypertensive patients treated with 3 risk factors in primary prevention, with or without associated hyperlipidaemia.
- Prevention of coronary and cerebra vascular events in type 2 diabetic patients with another risk factor, with or without associated hyperlipidaemia.
API
Atorvastatin
Therapeutic area
Alphaglucosidase inhibitor + Metabolism and Nutrition
Forms
Coated tablets
Dosage
80 mg
Presentation
B/30
Table
A